Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ABHI 30: NHS Long-Term Plan Promises Diagnosis And Tech Uptake Boost For Industry And Patients

Executive Summary

The over-running NHS England Long-Term Plan, to be released in full on Jan. 7, was a central discussion theme at the ABHI’s Market Conference last fall, an occasion that marked 30 years of the association’s support for industry. Early indications about the plan are that digital, early diagnosis, long-term and mental health care are among the key themes and challenges that will be addressed, and supported by the five-year funding boost announced last year. But is the cash settlement enough, and does the plan push the right buttons?

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT124454

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel